Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc

Fig. 3

Risk of evolution to definite systemic sclerosis in the validation cohort (replicated proteins). Survival estimates (Turnbull’s method) for dicothomized proteins (high/low serum levels) with prognostic significance in the validation cohort; time, years from blood draw. bFGF, basic fibroblast growth factor; PAF-AHβ, platelet-activating factor acetylhydrolase subunit beta

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us